This site limits showing results to the last 12 months. For full access, subscribe at CustomerGauge.com

NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution

Pharma, medtech & health distribution

Pharmaceuticals, biotech, medical devices, diagnostics and drug distribution. The companies below lead this vertical in what they say publicly about customer experience: how they score, how often they report it and what they disclose about retention.

65
Companies
with a public NPS or retention disclosure
74
NPS disclosures
21 companies gave a number
77
Median disclosed NPS
last 3 years · 39 scores
26
Report retention
NRR, GRR, retention rate, churn or renewal

Sub-verticals

Companies with a disclosure, by sub-vertical.

Lighthouse companies

Ranked on disclosed NPS (how often and how recently), Fortune 500 and listed status, and retention reporting. Click a card for every disclosure and its source.

Lumexa Imaging
Medical devices · lumexaimaging.com
LMRI7 NPS disclosures
90NPS · 2026
20252026
“Lumexa Imaging reports Net Promoter Scores above 90 and record employee engagement.”
— reported by tipranks.com · 21 Aug 2026
Latest: tipranks.com
NeoGenomics, Inc.
Diagnostics & labs · neogenomics.com
NEO4 NPS disclosures
77NPS · 2026
20262026
“NeoGenomics reported Net Promoter Scores in the high 70s across both segments as it expands its commercial representative force.”
— reported by tipranks.com · 15 Aug 2026
Latest: tipranks.com
Owlet
Medical devices · owletcare.com
OWLT4 NPS disclosures
77NPS · 2026
20262026
“Owlet reported a Dream Sock Net Promoter Score of 77% and blended product NPS of 71% at the end of Q1.”
— reported by inkl.com · 14 May 2026
Latest: inkl.com
SOPHiA GENETICS
Diagnostics & labs · sophos.com
SOPH
67NPS · 2026
20262026
NRR 117% · 2026Churn 0.4% · 2026
“Expanding usage of SOPHiA DDM™ with existing customers In 2025, we continued to delight our customers and, in doing so, drive meaningful expansion across accounts. We rec…”
— SOPHiA GENETICS · SEC 6-K report · filed 8 May 2026
Latest: SEC 6-K report
IDEXX Laboratories
Diagnostics & labs · idexx.com
IDXX
57NPS · 2026
Retention 95% · 2026
“Service in the United States; + Conducted three international commercial expansions in Australia, Germany and the United Kingdom, while expanding our U.S. field-based res…”
— IDEXX Laboratories · SEC proxy statement · filed 27 Mar 2026
Latest: SEC proxy statement
Fresenius Medical Care AG
Diagnostics & labs · freseniusmedicalcare.com
FMS
73NPS · 2026
20262026
“Of care and employee engagement relevant to the Group, which emerged from the most recent materiality analysis in 2023. To determine the target achievement, the values re…”
— Fresenius Medical Care AG · SEC 20-F annual report · filed 24 Feb 2026
Latest: SEC 6-K report
Myriad Genetics
Diagnostics & labs · myriad.com
MYGN
72NPS · 2026
20262026
“Also in 2025, our healthcare provider Net Promoter Score was 72.5, a level typically regarded as excellent, reflecting our continued focus on and investment in the patien…”
— Myriad Genetics · SEC proxy statement · filed 14 Apr 2026
Latest: SEC proxy statement
QIAGEN N.V.
Diagnostics & labs · qiagen.com
QGEN
76NPS · 2026
Latest: SEC 6-K report
HeraMED
Medical devices · heramed.com
60NPS · 2026
20262026
“HeraMED's HeraCARE Hybrid Maternity Care Solution achieved an NPS of 60 in its staged rollout with Lee Health System.”
— reported by smallcaps.com.au · 16 Sep 2026
Latest: smallcaps.com.au
Kinomatic
Medical devices · kinomatic.com
85NPS · 2026
Latest: pulse2.com
Piramal Pharma Solutions
Pharmaceuticals · piramal.com
55NPS · 2025
“Piramal Pharma Solutions achieved a Net Promoter Score of 55, exceeding industry averages in a third-party assessment by DNV.”
— reported by prnewswire.com · 15 Dec 2025
Latest: prnewswire.com
Scantox
Biotech · scantox.com
1NPS · 2026
“Scantox's Employee Net Promoter Score fell sharply from 50 to 1 over three years.”
— reported by medwatch.com · 25 Sep 2026
Latest: medwatch.com

White space

26 of 31 Fortune 500 companies in pharma, medtech & health distribution (84%) have never said publicly that they measure NPS: not in news coverage, SEC filings or earnings calls.

McKesson
Fortune 500 #8
Reports retention
Fortune 500 #10
Johnson & Johnson
Fortune 500 #44
Eli Lilly
Fortune 500 #65
Merck
Fortune 500 #66
Reports retention
Pfizer
Fortune 500 #69
AbbVie
Fortune 500 #73
Bristol-Myers Squibb
Fortune 500 #90
Thermo Fisher Scientific
Fortune 500 #98
Abbott Laboratories
Fortune 500 #99
Reports retention
Amgen
Fortune 500 #120
Gilead Sciences
Fortune 500 #142
Medline
Fortune 500 #148
Reports retention
Stryker
Fortune 500 #170
Danaher
Fortune 500 #175
Boston Scientific
Fortune 500 #211
IQVIA Holdings
Fortune 500 #255
Regeneron Pharmaceuticals
Fortune 500 #293
Fortune 500 #297
Henry Schein
Fortune 500 #313
Vertex Pharmaceuticals
Fortune 500 #347
Reports retention
Accendra Health
Fortune 500 #382
Biogen
Fortune 500 #395
Fortune 500 #441
Zimmer Biomet Holdings
Fortune 500 #446

Checked against every news item, SEC filing and earnings call in the database. "Reports retention" means the company publishes a retention or churn figure but no NPS.

Latest NPS disclosures

See all 74 in the database →

2026-10-22
—
Getinge's net promoter score reached an all-time high in Q3 2026, alongside strong employee engagement metrics. investing.com ↗
2026-10-20
4
Alternative PBM Net Promoter Score fell from +16 to +4, declining relative to Big Three PBMs; customer satisfaction metrics also declined. drugchannels.net ↗
2026-10-13
—
DexCom G7 Net Promoter Scores have risen for three consecutive quarters, reflecting improved customer feedback. tradingview.com ↗
2026-09-27
—
Microbot Medical reported high user satisfaction with LIBERTY System in survey results. quiverquant.com ↗
2026-09-25
1
Scantox's Employee Net Promoter Score fell sharply from 50 to 1 over three years. medwatch.com ↗
2026-09-23
—
Kinomatic demonstrates industry-leading Net Promoter Score and concierge model reducing post-surgical opioid use. manilatimes.net ↗
2026-09-23
—
MiniMed management said success should be judged by pipeline execution, launch performance and net promoter score trends. investing.com ↗
2026-09-23
—
Everlab demonstrates high patient trust with a staggering Net Promoter Score and $65 million Series A funding. campaignbrief.com ↗
2026-09-22
80
Australian Clinical Labs achieved Net Promoter Score above 80 based on 440,007 responses in 2026 Annual Report. kalkinemedia.com ↗
2026-09-16
60
HeraMED's HeraCARE Hybrid Maternity Care Solution achieved an NPS of 60 in its staged rollout with Lee Health System. smallcaps.com.au ↗
2026-09-01
94
VedaBio partner UCP Merchant Medicine reports Net Promoter Score of 94 against an industry average of 71. biospace.com ↗
2026-08-21
90
Lumexa Imaging reports Net Promoter Scores above 90 and record employee engagement. tipranks.com ↗

More companies in Pharma, medtech & health distribution

Number of entries in brackets.

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.